Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Chronic Kidney Disease Stage 3B
- Chronic Kidney Disease stage4
- Diabetes Mellitus - Type 2
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: This is a multicentre randomized double-blinded controlled trial lasting 20 weeks with two study periods. The first 12 weeks will constitute a treatment period with BSE (BSE group) or placebo (Control group) depending on the randomization of the group allocation. After that, patients from both groups will be followed for another eigth weeks, called post-study observational period.Masking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 90 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04858854
- Collaborators
- Lantmännen
- Investigators
- Principal Investigator: Peter x Stenvinkel, MD Karolinska Institutet Study Chair: Carla Avesani, PhD Karolinska Institutet Study Director: Marie Evans, MD Karolinska Institutet